ERA PerMed: Research Projects on Personalised Medicine

Through its fifth transnational call, ERA PerMed aims to foster research on prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels:
i. preventive measures decreasing the rate of incidence (primary prevention),
ii. early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and
iii. interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention).

Each project proposal MUST include clinical research (module 1B).

Research Area 1: Translating basic to clinical research and beyond

Research Area 2: Data and ICT

Research Area 3: Research towards responsible implementation in healthcare

A consortium of 3-6 partners from a minimum of 3 countries is required.

Funding: €140,000 total for the Israeli partner (optional €20,000 for coordination)

Duration: 3 years

Research Authority due date: 10.2.22

Pre proposal (required) due date: 17.2.22

MOH will fund maximum 2 proposals from Israeli applicants.